Timeline
Pharma
Broker pitches Sell on AstraZeneca, sees steep downside
Shield Therapeutics pediatric trial results published in journal
Health & Bio Today: Cambridge Cognition grows revenue 16% in H1, AOTI, Tristel, AstraZeneca, Faron Pharmaceuticals
Faron reports encouraging survival data in blood cancer trial
AstraZeneca's Ultomiris misses primary goal in adult transplant complication trial
AstraZeneca's Sone-Ve hits survival goal in gastric cancer trial
AstraZeneca lifts H1 profit as oncology offsets Farxiga decline
Health & Bio Today: Scancell to merge with Neuphoria in $89m Nasdaq deal, ProBiotix Health, hVIVO, Creo Medical, AstraZeneca
Scancell to merge with Neuphoria in Nasdaq listing and $89m financing
ProBiotix strikes Belgian supply deal with Nutrisan
The Premarket Brief: Frasers extends Accent Group offer, Mitchells & Butlers, Anglo American, BT Group, easyJet, Centrica, AstraZeneca, AJ Bell
AstraZeneca wins EU approval for camizestrant breast cancer combination
Health & Bio Today: Tristel confirms full-year growth targets met, Cambridge Raman Imaging, ImmuPharma
Cambridge Raman Imaging wins €400,000 EU grant, eyes pharma quality control
ImmuPharma picks Thermo Fisher for Kapiglucagon manufacturing
Health & Bio Today: EDX Medical rolls out bowel cancer test across UK, Novo Nordisk sues Eli Lilly over ad claims
Poolbeg wins Israeli patent allowance for POLB 001
Health & Bio Today: Sareum clears toxicology hurdle for psoriasis drug, Advanced Medical Solutions, GSK
GSK still needs wins in its drug pipeline says analyst
Sareum completes toxicology dosing for psoriasis drug candidate
The Morning Brief: Segro, South32, GSK, Ryanair, Big Yellow
GSK's Bexsero booster filing accepted by EMA
Health & Bio Today: Eli Lilly to acquire AtaiBeckley depression asset, GSK, Thalia Therapeutics
GSK drops camlipixant after mixed phase III cough trial results
Eli Lilly to acquire Biotech Growth Trust holding AtaiBeckley
Health & Bio Today: Poolbeg raises £3.5m for trials, CelLBxHealth, Genus, genedrive, Spire Healthcare, AstraZeneca
Small Caps Today: Poolbeg Pharma raises £3.5m as Friel backs placing, Rank Group, Boohoo, Ironveld, Headlam
AstraZeneca licenses lung cancer drug for up to $1.5bn
Poolbeg Pharma raises £3.5m as executive chair backs placing
Genedrive appoints Graham Cole as new chairperson
Health & Bio Today: Genflow's dog longevity data holds up, Aptamer Group, GSK
Poolbeg doses first patient in POLB 001 TOPICAL trial
Zenith Energy adds second Rome solar site, pipeline hits 193 MWp
Ondine pushes back Phase 3 nasal infection study readout
GSK's Jemperli hits primary goal in rectal cancer trial
Health & Bio Today: Minister cites Genedrive hearing test in Commons, GSK
Hansoh Phase III win bolsters GSK's global case for Ris-Rez in lung cancer
Health & Bio Today: AstraZeneca ATTR-CM trial fails primary endpoint, Avacta, Spire Healthcare, Smith+Nephew
AstraZeneca and Ionis ATTR-CM trial fails primary endpoint
OKYO Pharma accelerates urcosimod into Phase 3 after FDA validates trial design
Physiomics wins contracts across two service lines
Segro doubles new rent secured in first half as development pipeline hits record
Coiled Therapeutics advances softgel formulation ahead of dose expansion
MedPal AI raises £5m to acquire care-home software firm and launch oral Wegovy clinic
The Premarket Brief: MedPal AI raises £5m for care-home software and oral Wegovy clinic, Helix Exploration, Harbour Energy, Craneware, Ilika
PureTech spins out Celea Therapeutics with $180m Raise
Supermarket Income REIT completes £445m debt refinancing at lower margin
ECO Animal Health launches poultry vaccine ECOVAXXIN MS across EU
Physiomics promotes Head of Biometrics to Chief Operating Officer
More in Healthcare
GENinCode genetic test cuts cardiac risk in Catalonia pilot
A real-world pilot by Catalonia's health service found GENinCode's CARDIO inCode-Score reclassified risk in over 40% of moderate-risk patients and drove measurable improvements in cholesterol and smoking cessation.
Companies in Pharma
- AstraZeneca AZN
- GSK LSE:GSK
- Bsf Enterprise LSE:BSFA
- Seagate Technology AIM:STX
- Solvonis Therapeutics LSE:SVNS
- Eco Animal Health AIM:EAH
- Novo Nordisk NVO
- Beximco Pharmaceuticals LSE:BXP
- Nuformix LSE:NFX
- Hikma Pharmaceuticals LSE:HIK
- Novo Nordisk A/S 0QIU
- Avere Therapeutics Nasdaq:AVRX
- Eli Lilly NYSE:LLY
- Kailera Nasdaq:KLRA